SEC Filing

Investor Contacts

Katherine A. Littrell, PhD, RN
Vice President, Investor Relations

Diane H. Schrick
Senior Director, Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filing Details

Document Details

Filing Date
Nov 3, 2020
Document Date
Nov 3, 2020
Form Description
Post-effective amendment to an S-8 filing
Filing Group
Registration Statements
Company
Jazz Pharmaceuticals plc
Issuer
Jazz Pharmaceuticals plc